Modulating cGMP signaling limits cancer cell proliferation and survival [38,39], and IRAK3 contributes to the progression of both inflammation and cancer, likely via modulation of NFκB signaling, which provides a critical link between both conditions [40,41,42]. This evidence concerns the gene NFKB1 and cancer.